CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the second quarter ended June 30, 2016.
Revenue for the second quarter of 2016 was $12.5 million, an increase of 64% over the prior year period.
Revenue for the second quarter of 2016 was $12.5 million, an increase of 64% over the prior year period.
